Reduced Corneal Nerve Fiber Density in Patients With HIV

Share this content:
Reduced Corneal Nerve Fiber Density in Patients With HIV
Reduced Corneal Nerve Fiber Density in Patients With HIV

MONDAY, June 12, 2017 (HealthDay News) -- Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density, which can be identified using in vivo corneal confocal microscopy (IVCCM), according to a study published online June 8 in JAMA Ophthalmology.

Harriet I. Kemp, B.M., B.Ch., from Imperial College London, and colleagues conducted a cross-sectional study involving 20 patients who were HIV positive (14 with HIV-SN). They underwent IVCCM, and the images were analyzed. Results were compared with those from 20 age- and sex-matched healthy control participants.

The researchers observed a reduction in corneal nerve fiber density for patients with HIV versus controls (median difference, −10.37 mm²) and for patients with HIV-SN versus those without (median difference, −4.53 mm²). Patients with HIV had reduced corneal nerve branch density (median difference, −24.53 mm²) and corneal nerve fiber length (−5.24 mm/mm²); there were no differences seen for those with and without neuropathy. There was an increase in tortuosity coefficient for patients with HIV versus controls (median difference, 2.34) and in those with HIV-SN versus those without (median difference, 4.32). No significant differences were seen between the groups for corneal Langerhans cell density.

"In vivo corneal confocal microscopy could be used in the assessment of HIV-SN, but larger studies are required to confirm this finding," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Gene Tx Approved for Certain Types of B-Cell Lymphoma

Gene Tx Approved for Certain Types of B-Cell ...

First such treatment for certain types of non-Hodgkin lymphoma

Uninsurance Down by One-Third for Cancer Diagnoses in 2014

Uninsurance Down by One-Third for Cancer Diagnoses in ...

Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA

Diabetes Ups Risk of MACE in Acute Coronary Syndromes

Diabetes Ups Risk of MACE in Acute Coronary ...

Diabetes, but not pre-diabetes, tied to increased risk of major adverse cardiac events in adjusted model

is free, fast, and customized just for you!

Already a member?

Sign In Now »